| Line 1: |
Line 1: |
| | + | {{OpenPagesTop}} |
| | Also known as: '''''Intracutaneous Cornifying Epithelioma — Infundibular Keratinising Acanthoma''''' | | Also known as: '''''Intracutaneous Cornifying Epithelioma — Infundibular Keratinising Acanthoma''''' |
| | | | |
| Line 8: |
Line 9: |
| | It is seen most frequently in dogs between 4 and 9 years of age. | | It is seen most frequently in dogs between 4 and 9 years of age. |
| | | | |
| − | ==Clinical signs== | + | ==Clinical Signs== |
| | Keratoacanthomas develop most commonly on the '''back, tail and neck'''. | | Keratoacanthomas develop most commonly on the '''back, tail and neck'''. |
| | | | |
| − | The neoplasm generally appears as a '''well-circumscribed dermal or subcutaneous mass''' ranging in size from 0.4 to 4 cm in diameter, with a pore that opens to the skin surface. The '''pore''' may be filled with inspissated keratinous material which can be expulsed by appying digital pressure to the mass. A '''keratinised plug''' may protrude from the pore and, if large, may appear as a cutaneous horn. | + | The neoplasm generally appears as a '''well-circumscribed dermal or subcutaneous mass''' ranging in size from 0.4 to 4 cm in diameter, with a pore that opens to the skin surface. The '''pore''' may be filled with inspissated keratinous material which can be expressed by appying digital pressure to the mass. A '''keratinised plug''' may protrude from the pore and, if large, may appear as a cutaneous horn. |
| | | | |
| | If the neoplasm does not communicate with the skin surface it appears as an encapsulated intradermal mass. If the tumour wall becomes disrupted, keratin leaks into the surrounding tissues, evoking a '''foreign body reaction''' and a severe inflammatory response. | | If the neoplasm does not communicate with the skin surface it appears as an encapsulated intradermal mass. If the tumour wall becomes disrupted, keratin leaks into the surrounding tissues, evoking a '''foreign body reaction''' and a severe inflammatory response. |
| Line 36: |
Line 37: |
| | | | |
| | Retinoids have numerous '''side-effects''' including: conjunctivitis, hyperactivity, pruritus, vomiting, diarrhoea, stiffness, erythema at the mucocutaneous junction and teratogenic effects. These should be monitored for, although they are usually self-limiting and disappear when the drug is stopped. | | Retinoids have numerous '''side-effects''' including: conjunctivitis, hyperactivity, pruritus, vomiting, diarrhoea, stiffness, erythema at the mucocutaneous junction and teratogenic effects. These should be monitored for, although they are usually self-limiting and disappear when the drug is stopped. |
| | + | |
| | + | {{Learning |
| | + | |flashcards = [[Small Animal Dermatology Q&A 01]] |
| | + | }} |
| | | | |
| | ==References== | | ==References== |
| Line 44: |
Line 49: |
| | Kahn, C. (2005) '''Merck Veterinary Manual''' ''Merck and Co'' | | Kahn, C. (2005) '''Merck Veterinary Manual''' ''Merck and Co'' |
| | | | |
| − | [[Category:To Do - Helen]] | + | |
| − | [[Category:To Do - Review]] | + | {{review}} |
| | + | |
| | + | ==Webinars== |
| | + | <rss max="10" filter="dogs" highlight="none">https://www.thewebinarvet.com/oncology/webinars/feed</rss> |
| | + | |
| | + | [[Category:Neoplasia]] |
| | + | [[Category:Dermatological Diseases - Dog]] |
| | + | [[Category:Expert Review - Small Animal]] |